The Wall Street Basement: A Survival Guide to 10 Micro-Cap MisfitsGlobal Report·3 hours agoLAB+2.68%ZYBT+10.57%
Margin Over Volume: How Xylem and Levi Strauss Navigate the 2026 Earnings SeasonGlobal Report·1 day ago, 04:14 AMENVX+13.59%LAB+2.68%
Standard BioTools amends 8-K to file mass cytometry sale agreement with Multiplex BioPUBT·2 days ago, 07:16 AMLAB+2.68%
Standard BioTools to sell mass cytometry business to Multiplex Bio for up to $10 millionPUBT·Jul 28 at 07:04 AMLAB+2.68%
Leveraged ETFs and Event-Driven Stocks See Tactical Inflows Amid Tech Sector SelloffGlobal Report·Jul 28 at 04:12 AMLAB+2.68%
Navigating Cross-Border Currents: Sector Divergence and Strategic Pivots in a Fragmented 2026 MarketGlobal Report·Jul 25 at 04:13 AMGNRC-1.68%TGTX+9.00%
Standard BioTools gets Nasdaq notice for failing $1 minimum bid price rulePUBT·Jul 24 at 03:39 PMLAB+2.68%
The AI Spillover: How the Market's Edges are Rewiring Real InfrastructureGlobal Report·Jul 24 at 04:13 AMDXST-0.88%BRIA-3.91%
Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?PR Newswire·Jul 21 at 01:53 PMRLYB+0.69%LAB+2.68%
